Abstract Phytocannabinoids, with their variety of beneficial effects, represent a valid group of substances that could be employed as neurogenesis-enhancers…
Abstract Cannabigerol (CBG) is a non-psychoactive phytocannabinoid present in the Cannabis sativa L. plant. In our study, CBG at the…
Abstract Parkinson’s disease (PD) is the second most frequent neurodegenerative disease and currently represents a clear unmet medical need. Therefore,…
Abstract Recently, the scientific community has started to focus on the neurogenic potential of cannabinoids. The phytocompound cannabidiol (CBD) shows…
Abstract Cannabis sativa L. proved to be a source of several phytocompounds able to help patients facing different diseases. Moreover,…
Abstract Spinal cord injury affects the lives of millions of people around the world, often causing disability and, in unfortunate…
Abstract The concept of neurons as irreplaceable cells does not hold true today. Experiments and evidence of neurogenesis, also, in…
Abstract Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects including antioxidant and anti-inflammatory properties. Moreover, CBD is…
Abstract More than 120 cannabinoids were isolated from Cannabis sativa. In particular, Cannabidiol (CBD) and Cannabigerol (CBG) represent the two…
Abstract Inflammation is a common feature of many neurodegenerative diseases. The treatment of stem cells as a therapeutic approach to…